Delivery Order SPE2DR25D1017-SPE2DR26F9EUM

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for $32,489.23 (firm fixed price) for Actemra Actpen 162 mg/0.9 ml pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 11, 2026. The order carries a ceiling value of $32,489.23 and was issued under no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Actemra Actpen 162 mg/0.9 ml auto-injector pharmaceutical product, with a ceiling value of $15,620.70.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of February 9, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, for Actemra 162 mg/0.9 mL syringes with a ceiling value of $2,252.22.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 9, 2026. The order is priced on a firm fixed-price basis and carries no set-aside.</p>

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $25,485.10 for supply of Actemra Actpen 162 mg/0.9 mL auto-injector units. Place of performance is Conshohocken, PA 19428. The order matures February 10, 2026. This is a firm fixed-price delivery order issued under no set-aside. The parent vehicle is the DLA Troop Support Medical indefinite delivery contract held by Cencora, Inc. (parent of the awardee), valued at...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $58,983.31 for supply of Actemra 162 mg/0.9 mL syringes. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Actemra 162 mg/0.9 ml syringes with a ceiling value of $12,043.64. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract valued at up to $999,999,999.00 through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order...

The Defense Logistics Agency awarded a delivery order valued at $5,863.20 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Actemra Actpen (162 mg/0.9 mL) pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under AmerisourceBergen...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,003.48 to Amerisourcebergen Drug Corp on January 6, 2026, for the supply of Actemra ActPen 162 mg/0.9 ml injectable medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. Amerisourcebergen Drug Corp is...

The Defense Logistics Agency awarded a $3,003.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Actemra ActPen 162 mg/0.9 ml injectable medication. This is a non-set-aside competitive award with a completion date of January 23, 2026, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...

The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Actemra ActPen (162 mg/0.9 mL) auto-injectors. This firm fixed price delivery order carries a ceiling value of $3,066.26 and is scheduled for completion by August 19, 2025. The contract was competitively awarded without set-aside provisions, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements....